4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-22-002257
Chief Medical Officer sold 5,000 shares at an average $37.19 ($185,956)
- Chief Medical Officer acquired 5,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2022-01-05 | Option exercise | +5,000 | $1.53 | $7,650 | 97,777 | D: show line 1 in the form |
| Pang Phillip Chief Medical Officer | 2022-01-05 | Sale | −4,600 | $37.14 | $170,844 | 93,177 | D: show line 2 in the form |
| Pang Phillip Chief Medical Officer | 2022-01-05 | Sale | −400 | $37.78 | $15,112 | 92,777 | D: show line 3 in the form |
| Open-market sales · 5,000 sh · avg $37.19 · $185,956 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2022-01-05 | Option exercise · Stock Option (Right to Buy) | −5,000 | 67,591 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…